Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion.

Boffini M, Ricci D, Bonato R, Fanelli V, Attisani M, Ribezzo M, Solidoro P, Del Sorbo L, Ranieri VM, Rinaldi M.

Eur J Cardiothorac Surg. 2014 Nov;46(5):789-93. doi: 10.1093/ejcts/ezu239.

PMID:
25061216
2.

Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study.

Wallinder A, Ricksten SE, Silverborn M, Hansson C, Riise GC, Liden H, Jeppsson A, Dellgren G.

Eur J Cardiothorac Surg. 2014 Jan;45(1):40-4; discussion 44-5. doi: 10.1093/ejcts/ezt250.

PMID:
23666375
3.

Lung transplantation from initially rejected donors after ex vivo lung reconditioning: the French experience.

Sage E, Mussot S, Trebbia G, Puyo P, Stern M, Dartevelle P, Chapelier A, Fischler M; Foch Lung Transplant Group..

Eur J Cardiothorac Surg. 2014 Nov;46(5):794-9. doi: 10.1093/ejcts/ezu245.

PMID:
25061219
4.

Is it possible to further improve the function of pulmonary grafts by extending the duration of lung reconditioning using ex vivo lung perfusion?

Pierre L, Lindstedt S, Hlebowicz J, Ingemansson R.

Perfusion. 2013 Jul;28(4):322-7. doi: 10.1177/0267659113479424.

PMID:
23436723
5.

Histologic and functional evaluation of lungs reconditioned by ex vivo lung perfusion.

Medeiros IL, Pêgo-Fernandes PM, Mariani AW, Fernandes FG, do Vale Unterpertinger F, Canzian M, Jatene FB.

J Heart Lung Transplant. 2012 Mar;31(3):305-9. doi: 10.1016/j.healun.2011.10.005.

PMID:
22133788
6.

Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation.

Valenza F, Rosso L, Coppola S, Froio S, Palleschi A, Tosi D, Mendogni P, Salice V, Ruggeri GM, Fumagalli J, Villa A, Nosotti M, Santambrogio L, Gattinoni L.

Transpl Int. 2014 Jun;27(6):553-61. doi: 10.1111/tri.12295.

7.

Ex vivo lung perfusion increases the pool of lung grafts: analysis of its potential and real impact on a lung transplant program.

Boffini M, Ricci D, Barbero C, Bonato R, Ribezzo M, Mancuso E, Attisani M, Simonato E, Magistroni P, Mansouri M, Solidoro P, Baldi S, Pasero D, Amoroso A, Rinaldi M.

Transplant Proc. 2013 Sep;45(7):2624-6. doi: 10.1016/j.transproceed.2013.08.004.

PMID:
24034008
8.

Transplantation of initially rejected donor lungs after ex vivo lung perfusion.

Wallinder A, Ricksten SE, Hansson C, Riise GC, Silverborn M, Liden H, Olausson M, Dellgren G.

J Thorac Cardiovasc Surg. 2012 Nov;144(5):1222-8. doi: 10.1016/j.jtcvs.2012.08.011.

9.

Clinical Outcome of Patients Transplanted with Marginal Donor Lungs via Ex Vivo Lung Perfusion Compared to Standard Lung Transplantation.

Fildes JE, Archer LD, Blaikley J, Ball AL, Stone JP, Sjöberg T, Steen S, Yonan N.

Transplantation. 2015 May;99(5):1078-83. doi: 10.1097/TP.0000000000000462.

PMID:
25757211
10.

An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.

Fisher A, Andreasson A, Chrysos A, Lally J, Mamasoula C, Exley C, Wilkinson J, Qian J, Watson G, Lewington O, Chadwick T, McColl E, Pearce M, Mann K, McMeekin N, Vale L, Tsui S, Yonan N, Simon A, Marczin N, Mascaro J, Dark J.

Health Technol Assess. 2016 Nov;20(85):1-276.

11.

Factors associated with early graft dysfunction in cystic fibrosis patients receiving primary bilateral lung transplantation.

Felten ML, Sinaceur M, Treilhaud M, Roze H, Mornex JF, Pottecher J, Journois D, Fischler M.

Eur J Cardiothorac Surg. 2012 Mar;41(3):686-90. doi: 10.1093/ejcts/ezr019.

PMID:
22345188
12.

Experience with the first 50 ex vivo lung perfusions in clinical transplantation.

Cypel M, Yeung JC, Machuca T, Chen M, Singer LG, Yasufuku K, de Perrot M, Pierre A, Waddell TK, Keshavjee S.

J Thorac Cardiovasc Surg. 2012 Nov;144(5):1200-6. doi: 10.1016/j.jtcvs.2012.08.009.

13.

Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion.

Machuca TN, Cypel M, Yeung JC, Bonato R, Zamel R, Chen M, Azad S, Hsin MK, Saito T, Guan Z, Waddell TK, Liu M, Keshavjee S.

Ann Surg. 2015 Mar;261(3):591-7. doi: 10.1097/SLA.0000000000000974.

PMID:
25371129
14.

The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion.

Machuca TN, Cypel M, Zhao Y, Grasemann H, Tavasoli F, Yeung JC, Bonato R, Chen M, Zamel R, Chun YM, Guan Z, de Perrot M, Waddell TK, Liu M, Keshavjee S.

J Heart Lung Transplant. 2015 Jun;34(6):849-57. doi: 10.1016/j.healun.2015.01.003.

PMID:
25907141
15.

Technique for prolonged normothermic ex vivo lung perfusion.

Cypel M, Yeung JC, Hirayama S, Rubacha M, Fischer S, Anraku M, Sato M, Harwood S, Pierre A, Waddell TK, de Perrot M, Liu M, Keshavjee S.

J Heart Lung Transplant. 2008 Dec;27(12):1319-25. doi: 10.1016/j.healun.2008.09.003.

PMID:
19059112
16.

Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.

Samano MN, Fernandes LM, Baranauskas JC, Correia AT, Afonso JE Jr, Teixeira RH, Caramori ML, Pêgo-Fernandes PM, Jatene FB.

Transplant Proc. 2012 Oct;44(8):2462-8. doi: 10.1016/j.transproceed.2012.07.134.

PMID:
23026621
17.

Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.

Mizota T, Miyao M, Yamada T, Sato M, Aoyama A, Chen F, Date H, Fukuda K.

Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):314-20. doi: 10.1093/icvts/ivv357.

18.

Ex-vivo lung perfusion.

Sanchez PG, D'Ovidio F.

Curr Opin Organ Transplant. 2012 Oct;17(5):490-5. doi: 10.1097/MOT.0b013e328357f865. Review.

PMID:
22941323
20.

A novel dual ex vivo lung perfusion technique improves immediate outcomes in an experimental model of lung transplantation.

Tanaka Y, Noda K, Isse K, Tobita K, Maniwa Y, Bhama JK, D'Cunha J, Bermudez CA, Luketich JD, Shigemura N.

Am J Transplant. 2015 May;15(5):1219-30. doi: 10.1111/ajt.13109.

Items per page

Supplemental Content

Support Center